RT Journal Article
T1 Future Challenges and Critical Approach to Metrology in Patients with Axial Spondyloarthritis.
A1 Garrido-Castro, Juan L
A1 Collantes-Estevez, Eduardo
A1 Alburquerque-Sendin, Francisco
A1 Lopez-Medina, Clementina
K1 Humans
K1 Spondylitis, ankylosing
K1 Quality of life
K1 Rheumatologists
K1 Spondylarthritis
AB Axial spondyloarthritis (axSpA) is a rheumatic inflammatory chronic disease thatmainly affects the spine, producing inflammation and structural damage at the vertebral level (erosions, syndesmophytes, and bony bridges). This leads to a reduction of mobility in axSpA patients [1] that requires assessment by rheumatologists to closely monitor patients and analyse the efficacy of prescribed treatments. Several tools are used for the evaluation of these patients [2]; thus, self-assessed patient report outcomes (PRO)  questionnaires may be completed by the patient to evaluate function (Bath Ankylosing Spondylitis Functional Index—BASFI), whereas other tools monitor disease activity (Bath Ankylosing Spondylitis Disease Activity Index—BASDAI) and the patient’s quality of life (Assessment of SpondyloArthritis International Society Health Index—ASAS-HI), among others. In addition, other indexes are used to analyse radiographic structural damage (modified Stoke Ankylosing Spondylitis Spinal Score—mSASSS) and activity indexes based on blood tests (Ankylosing Spondylitis Disease Activity Score—ASDAS).
SN 2075-4418
YR 2021
FD 2021-08-23
LK http://hdl.handle.net/10668/18567
UL http://hdl.handle.net/10668/18567
LA en
NO Garrido-Castro JL, Collantes-Estévez E, Alburquerque-Sendín F, López-Medina C. Future Challenges and Critical Approach to Metrology in Patients with Axial Spondyloarthritis. Diagnostics (Basel). 2021 Aug 25;11(9):1533
DS RISalud
RD Apr 5, 2025